Last reviewed · How we verify

NCT05652270: mGAME

Maximizing Patient Goal Attainment

Active, enrolled NA Last updated 1 April 2026
What this trial tests

NA trial testing Goal Attainment in Knee Osteoarthritis in 258 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
30 May 2023
Primary endpoint
1 June 2026
4 February 2027

Quick facts

Lead sponsorDartmouth-Hitchcock Medical Center
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment258
Start date30 May 2023
Primary completion1 June 2026
Estimated completion4 February 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Dartmouth-Hitchcock Medical Center

Who can join

21 and older, any sex, with Knee Osteoarthritis or Knee Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the effectiveness of the goal development intervention in guiding individual patients through the identification of high quality, specific, measurable, relevant and time-bound goal for treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

Other Dartmouth-Hitchcock Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05652270.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing